Success Stories: Indian Postdoctoral Associate Secures NIW Approval for Research on Maternal-Fetal Health

Client’s Testimonial:

“Thank you so much for your support throughout this process! It is great to know that the hard part of the process is over.”

On August 28^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the field of Cell and Molecular Biology (Approval Notice).

General Field: Cell and Molecular Biology

Position at the Time of Case Filing: Postdoctoral Associate

Country of Origin: India

State of Residence at the Time of Filing: Texas

Approval Notice Date: August 28^th, 2025

Processing Time: 2 months, 1 day (Premium Processing Requested)

Case Summary:

An EB-2 NIW (National Interest Waiver) has been approved for a postdoctoral associate from India whose research is helping to transform the understanding and treatment of adverse pregnancy outcomes. At the time of filing, the client was conducting advanced research in the United States, focused on uncovering how viral infections and maternal conditions such as obesity disrupt pregnancy. His strong record of publications, citations, and professional service made him a compelling candidate for NIW approval.

Research that Addresses National Priorities

The client’s work applies molecular biology and innovative placenta-derived 3D organoid models to study how stressors impact fetal development. By pinpointing the biological mechanisms that cause complications, he identifies potential small-molecule therapies designed to safeguard both mother and child. This research directly addresses U.S. public health priorities, as maternal mortality and pregnancy complications remain urgent challenges. The client’s work aligns with national initiatives such as Healthy People 2030, which highlights the need to reduce maternal deaths and improve outcomes for women and infants.

A Record of Scholarly Excellence

The client’s academic record speaks for itself. He has authored 17 peer-reviewed journal articles, 2 abstracts, and 3 preprints, with 8 of these works bearing his name as first author. His publications in high-impact journals, including Cell Stem Cell and Nature Communications, have been cited more than 650 times. Several of these articles rank in the top 1 percent and top 10 percent of most cited works in their categories, demonstrating their broad influence.

Beyond authorship, he plays a role in shaping the field as a reviewer for Springer Nature journals and as a topic editor for Frontiers in Molecular Biosciences. These responsibilities underscore the recognition he has earned as a reliable authority in evaluating cutting-edge research.

Approval and Looking Forward

The I-140 NIW petition was filed on June 27, 2025, with premium processing, and approved on August 28, 2025. The approval reflects recognition of both his established achievements and the national importance of his ongoing work.

With the guidance of NAILG, the client has secured NIW approval and will continue his groundbreaking research in the United States. His contributions are expected to lead to safer pregnancies, healthier outcomes for mothers and children, and new innovations that strengthen the nation’s biomedical research leadership.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.